Certain pathogenic bacteria produce a family of heat stable enterotoxins (STa) which activate intestinal guanylyl cyclases, increase cGMP, and elicit life-threatening secretory diarrhea. The intracellular effector of cGMP actions has not been clarified. Recently we cloned the cDNA for a rat intestinal type II cGMP dependent protein kinase (cGK II) which is highly enriched in intestinal mucosa. Here we show that cGK II mRNA and protein are restricted to the intestinal segments from the duodenum to the proximal colon, with the highest amounts of cGK II protein in duodenum and jejunum. cGK II mRNA and protein decreased along the villus to crypt axis in the small intestine, whereas substantial amounts of both were found in the crypts of cecum. In intestinal epithelia, cGK II was specifically localized in the apical membrane, a major site of ion transport regulation. In contrast to cGK II, cGK I was localized in smooth muscle cells of the villus lamina propria. Short circuit current (ISC), a measure of Cl-secretion, was increased to a similar extent by STa and by 8-Br-cGMP, a selective activator of cGK, except in distal colon and in monolayers of T84 human colon carcinoma cells in which cGK II was not detected. In human and mouse intestine, the cyclic nucleotide-regulated Cl-conductance can be exclusively accounted for by the cystic fibrosis […] Certain of the profound effects of two major signal transduction systems, that of atrial natriuretic peptide (ANP)1 and endothelium derived relaxing factor (EDRF) or nitric oxide (NO), on the cardiovascular and renal systems are mediated by cGMP (1). In intestine, ANP increases cGMP and triggers ion fluxes and secretory responses (2, 3). Heat stable enterotoxins (STa) also increase cGMP in intestine and can cause lethal secretory diarrhea (4). Whereas cells in the lamina propria of intestinal villi contain a transmembrane guanylyl cyclase (GC-A) responsive to ANP (2, 3), both STa and an endogenous intestinal peptide called guanylin activate a different transmembrane receptor guanylyl cyclase, GC-C, in epithelial cells to increase cGMP (reviewed in references 5-7). Subsequent events triggered by STa leading to changes in intestinal fluid and electrolyte transport and secretory diarrhea are not entirely clear, however, increase in cGMP is thought to inhibit epithelial sodium chloride and water absorption and to activate epithelial chloride secretion (4). CFTR Cl -channels can fully account for cyclic nucleotide-elicited Cl-secretion in human and rat intestine since no electrogenic Cl -secretion is provoked by either cAMP or cGMP analogs or STa in intestinal epithelium of CF patients (7), and there is no Cl -secretion in response to guanylin in transgenic CF mice (8).
1. Abbreviations used in this paper: cAK, cAMP dependent protein kinase; CFTR, cystic fibrosis transmembrane conductance regulator; cGK, cyclic GMP dependent protein kinase; STa, heat stable enterotoxin.
Certain of the profound effects of two major signal transduction systems, that of atrial natriuretic peptide (ANP)1 and endothelium derived relaxing factor (EDRF) or nitric oxide (NO), on the cardiovascular and renal systems are mediated by cGMP (1) . In intestine, ANP increases cGMP and triggers ion fluxes and secretory responses (2, 3) . Heat stable enterotoxins (STa) also increase cGMP in intestine and can cause lethal secretory diarrhea (4) . Whereas cells in the lamina propria of intestinal villi contain a transmembrane guanylyl cyclase (GC-A) responsive to ANP (2, 3) , both STa and an endogenous intestinal peptide called guanylin activate a different transmembrane receptor guanylyl cyclase, GC-C, in epithelial cells to increase cGMP (reviewed in references 5-7). Subsequent events triggered by STa leading to changes in intestinal fluid and electrolyte transport and secretory diarrhea are not entirely clear, however, increase in cGMP is thought to inhibit epithelial sodium chloride and water absorption and to activate epithelial chloride secretion (4) . CFTR Cl -channels can fully account for cyclic nucleotide-elicited Cl-secretion in human and rat intestine since no electrogenic Cl -secretion is provoked by either cAMP or cGMP analogs or STa in intestinal epithelium of CF patients (7) , and there is no Cl -secretion in response to guanylin in transgenic CF mice (8) .
There are multiple effectors of cGMP action including cGMP gated channels, cGMP regulated phosphodiesterases, cGMP dependent protein kinases (cGK), and possibly cAMP dependent protein kinases (cAK) (1) . Cyclic GMP crossactivation of cAK has been described as a major mechanism by which STa elicits CFTR Cl -channel activation in T84 and Caco-2 human colon carcinoma cell lines (9) (10) (11) . Other studies on native intestinal epithelium however suggested that cGMP activation of Cl-secretion is mediated by a novel intestinal brush border isoform of cGK designated cGK II (reviewed in reference 7) . In the present study we address the question of the endogenous physiological effector of cGMP in intestine by localization of cGK isoforms and measurement of cGMP-provoked Cl-secretion. Mammalian cGK isoforms cGK Ia and I# from bovine trachea and human placenta (12, 13) 7 .0) and were pelleted by low speed centrifugation (1,500 g, 10 min) after the removal of nuclear aggegates with glasswool (3). BBMV were prepared from isolated rat intestinal villous cells or a human ileal segment by a freeze-thaw procedure and differential MgSO4 precipitation as described (24) .
Western blot analysis. Mucosa from different segments of intestine was homogenized in PBS containing protease inhibitors (5 jzg/ml leupeptin, 1.5 mM benzamidine, 200 U/ml aprotinin, 2 ,g/ml pepstatin A, 10 jg/ml PMSF, 1 mM EDTA) and samples were analyzed by Western blots using cGK H antiserum diluted 1:400 and 1 ACi "nI-protein A.
Samples for Western blots of human colon carcinoma cells, enterocytes and their subcellular fractions, or brush borders and brush border membrane vesicles, were analyzed differently by labeling with cGK H antibody diluted 1:3,000, followed by anti-rabbit IgG coupled to peroxidase diluted 1/3,000 (Tago, Burlingame, CA) and visualization by the enhanced chemiluminescence (ECL) method (Amersham, Braunschweig).
Short circuit current (Isc) measurements. Intestinal mucosa segments were isolated, and in some cases (i.e., cecum, proximal, and distal colon) the muscle layer was stripped off by blunt dissection. Mucosal segments were mounted in an Ussing chamber and short-circuit current (Isc) across an exposed area of the intestinal mucosa (0.3 cm2) was measured as previously described (25) . For measurements of Isc across filter-grown monolayers of T84 cells (see below), a different type of Ussing chamber was used (26) . The intestinal segments were incubated with purified heat stable enterotoxin (STa) and cyclic nucleotide analogs obtained from Sigma (Deisenhofen). The reported responses represent the maximal change in Isc provoked by a given secretogogue. Positive values for Isc denote a negative electrical charge flux from serosa to mucosa.
Cell culture. T84 and Caco-2 cells were obtained from ATCC and HT29-19A cells were a gift from Dr. C. L. Laboisse (Nantes, France). T84 cells were grown in Dulbecco's modified Eagle's medium (DME)/ Ham's F12 (1:1), 15 mM Hepes, and 5% fetal calf serum (FCS); Caco-2 cells in DME, 25 mM Hepes, 1% nonessential amino acids, and Figure 2 . Localization of cGK II mRNA in different segments of rat intestine by in situ hybridization. The labeling in dark-field views (A-E, with intestinal lumen at top of section) appears as aggregates of silver grains, whereas in bright-field views (F-H, intestinal lumen at right side of sections) labeling appears as black spots. Specific labeling with an 35S-labeled cGK II antisense RNA was found in epithelial cells of duodenum (C), jejunum (D), ileum (E), cecum (F), and proximal colon (G). No hybridization signal was found in distal colon (H) and stomach (A). A cGK II sense probe gave no significant labeling, as shown for duodenum (B). Specific labeling extended along the crypt to the upper villus in duodenum, jejunum and ileum (C-E), whereas specific labeling was greatest in the crypts, in comparison to the surface epithelium, in cecum (F), found to a small extent in both crypts and surface epithelium of proximal colon (G), and essentially undetectable in distal colon (H). The bar represents 100 pm. 
Results
Localization of cGK II mRNA in intestinal segments. Northern blot analysis of cGK II mRNA present in total RNA samples from enterocytes purified from rat intestinal segments is shown in Fig. 1 . A major band of 4.8 kb and minor bands at 6.2 and 3.1 kb were observed to be similar to those found previously in rat jejunum mucosal scrapings (15). cGK II mRNA was present in all intestinal segments extending from the duodenum to the proximal colon but was notably absent from the distal colon. The distribution of cGK II mRNA was also investigated in enterocytes fractionated by exposure to mechanical vibration. cGK II mRNA was highly expressed in the tip and mid regions of the villus and decreased from the mid-villus to the crypt region (data not shown).
Consistent with the Northern blot data ( Fig. 1 ), cGK II mRNA was shown by in situ hybridization to be most prominent in the small intestine segments of duodenum, jejunum, ileum, and cecum (Fig. 2, C-F) , with lesser amounts in proximal colon (Fig. 2 G) . cGK II mRNA was undetectable in distal colon (Fig. 2 H) , as well as stomach (Fig. 2 A) , and esophagus (not shown). The distribution of cGK II mRNA along the villus to crypt axis varied somewhat within the different segments. However, in the small intestine the strongest signal was observed in the mid villus region, with some labeling of crypts in duodenum and ileum. In the cecum, crypts were prominently labeled and the surface epithelium only moderately.
Endogenous cGK II protein expression in intestinal segments. The distribution of cGK II protein in mucosal scrapings analyzed on Western blots (Fig. 3 A) reflected that of cGK II mRNA in isolated enterocytes (Fig. 1 ) insofar as the major amount was in small intestinal segments and was absent in stomach and distal colon. Similar to cGK II mRNA (data not shown), cGK II protein (Fig. 3 B) decreased from the villus tip to the crypt of enterocytes.
With small exceptions, the distribution of cGK II observed by immunocytochemistry (Fig. 4) was basically similar to that observed by Western analysis (Fig. 3) . In small intestinal segments (Fig. 4, C-E) , cGK II labeling was most prominent in villi in comparison to crypts, whereas crypts were most strongly labeled in cecum (Fig. 4 F) . Again, cGK H was not detected in stomach (Fig. 4 A) and distal colon (Fig. 4 H) thelial cell itself appeared to be non-specific since it diminished in labelings performed with affinity-purified antibody, whereas all other labeling was unchanged (see Fig. 5 A) . Results obtained from Western analysis of subcellular fractions of enterocytes from jejunum-ileum (Fig. 3 C) agreed with the brush border localization of cGK II observed in small intestine by immunocytochemistry (Fig. 4) . cGK II was found exclusively in the membrane pellet after 100,000 g centrifugation of homogenates and was also shown to be enriched in fractions of brush border membrane vesicles and brush border caps. The latter fractions both represent microvilli including the cytoskeleton, except that the terminal web is absent from the brush border membrane vesicle fraction (27) .
Comparison of the localization of cGK I and cGK 1. The expression of cGK I and cGK H detected by immunocytochemistry in intestinal mucosa of duodenum is strikingly distinct (Fig. 5) . Whereas cGK H is localized in the brush border of epithelial cells (Fig. 5 A) , cGK I is exclusively in smooth muscle cells of the villus lamina propria (Fig. 5 B) and the major smooth muscle layers of the intestinal wall (data not shown). Faint staining of the brush border by cGK I antibody appeared to be unspecific since it was not eliminated by preabsorption of the antibody with cGK I, whereas staining of the lamina propria smooth muscle cells was (not shown). The differential localization of cGK H and cGK I is supported by the results of Western blots showing detection of only cGK II in enterocytes (Fig. 6 A) and only cGK I in smooth muscle tissue (SMC) (Fig. 6 B) . In addition, cGK I mRNA (7 kb) was not Table I . STa, 8-BrcGMP, and 8-Br-cAMP cause an increase in ISc with certain notable differences. The response to 8-Br-cAMP is consistently greater than that of the other two agents, except in cecum, in which prominent labeling of cGK H mRNA and protein was observed in crypts, a major site of Cl -secretion. Furthermore, in distal colon, where cGK II is absent, the response to 8-BrcAMP is preserved, whereas that of the agents which increase cGMP is not. It should be noted that these experiments were performed in the presence of indomethacin since otherwise effects of STa on cAMP hydrolysis have been observed in colon (28). Whereas STa caused a large increase in Isc in both human colon carcinoma T84 cells and native intestine, 8-Br-cGMP, a selective activator of cGK (29), could mimic this only in intestinal segments containing cGK II, and not in T84 cells (Table  I ). Thus the mechanism by which STa activates Cl -secretion in T84 cells appears to differ from that of native intestine (see Discussion).
Absence of cGK II and cGK I in human colon carcinoma cell lines. Because of the frequent use of human colon carcinoma cell lines as models of intestinal cell function in response to cGMP (see Discussion), we investigated the presence of cGK H and cGK I in such cells. Neither cGK II nor cGK I were detected in human T84, Caco-2, or HT29-19A cells at the film exposure (2 min) shown in Fig. 6 or after a 10-fold longer exposure (not shown). Both antibodies crossreact with their respective human antigens, as seen for cGK II in human BBMV (Fig. 6 A) , and as has been shown for cGK I in human platelets (30) . The lower band (Fig. 6 A) observed in the cell lines is considered to be unspecific rather than a degradation product of cGK II since cells were directly lysed in boiled SDS.
Discussion
STa enterotoxin-induced diarrhea causes many infant deaths in developing countries, is a leading cause of morbidity and death in domestic animals, and is considered a major cause of traveler's diarrhea (reviewed in reference 5). cGMP concentration increases elicited by STa result in net fluid secretion through the activation of epithelial apical Cl-transport and inhibition of coupled NaCl absorption (7). Both cGK H mRNA and protein were found only in intestinal segments between and including the duodenum and proximal colon. They were notably absent in the distal colon where STa and 8-Br-cGMP were unable to cause C1-secretion. Furthermore, cGK II was localized by in situ hybridization, immunocytochemistry, and fractionation to intestinal epithelial cells. At the subcellular level, cGK H protein was specifically localized to the epithelial cell brush Ussing chamber measurements of the increment in short circuit current induced by STa, border. This localization is consistent with that of the membrane guanylyl cyclase (GC-C) activated by STa and guanylin, as well as the localization of potential targets of cGMP action, CFTR and transporters for NaCl absorption (discussed below). In contrast, the localization of cGK I in smooth muscle cells of villi lamina propria, and its absence in mucosal scrapings and enterocytes, is not consistent with a role of cGK I in epithelial cell ion transport processes underlying secretory diarrhea. Substances that increase Cl-secretion in the intestine include ANP, or guanylin and STa (2, 3, 8) , which bind to transmembrane receptor guanylyl cyclases GC-A, or GC-C, respectively (31) . ANP, unlike STa, does not directly stimulate colonic epithelial cells but possibly provokes Cl -secretion indirectly by release of a neurotransmitter in the submucosa (3) . In situ hybridization with rat tissues showed GC-A mRNA expression in the villi lamina propria, whereas GC-C mRNA was found in epithelial cells (2, 32) . In rat colon GC-C mRNA was present in colonic crypts and surface epithelium (2); in rat small intestine, GC-C mRNA was more prominent in villar than crypt epithelium, and highest in the mid villus region (32) . A study of 1251-STa binding to its receptor in human and other mammalian intestines including rat, demonstrated that GC-C protein was greatest in enterocytes located near the basal half of the villi and in the proximal half of the crypts (33) . The distribution of GC-C, but not GC-A, closely resembles that of cGK II, thus only GC-C is appropriately situated to generate cGMP that can activate cGK II in intestinal epithelial cells. An endogenous intestinal peptide named guanylin was identified as the physiological mammalian equivalent of the pathogenic toxin STa for activating GC-C (5). A clear consensus concerning the localization of guanylin production is not available since it has been proposed to be in Paneth cells (34) , surface epithelial cells and epithelial cells of upper crypts (2, 35) , and in enterochromaffin cells (36) .
Potential targets of cGMP action for regulating ion transport are also located in intestinal epithelial cells. CFTR, which forms the major cyclic nucleotide regulated C1-secretory channel in intestine (reviewed in references 7 and 8), is located in the apical plasma membrane of Cl --secreting epithelia (37) . CFT R mRNA has been shown to decrease from crypts to villi and from the duodenum to the distal colon of the rat and human intestinal tract (38, 39) . The principal secretory activity of the A cGK 11 I
small and large intestine resides in the crypt compartment (4, 40 brush border Na' absorptive process which is inhibited in most diarrheal diseases, and which is composed of a Na+/H+ exchanger (NHE) linked to a C1-/HCO3 exchanger (43, 44) . Whereas several NHE forms have been described and cloned, of these only NHE-3 was both present in the apical rather than basolateral membrane and apparently epithelium specific (44) (45) (46) . In situ hybridization showed that NHE-3 mRNA was exclusively located in rat small intestinal villus cells and luminal epithelial cells of colon, and that NHE-3 protein was selectively localized in the brush border membrane (46) . So far, the mechanism of cGMP inhibition of the intestinal NHE has been addressed only in chicken enterocytes in which cGMP acts indirectly via Ca2" mobilization (47) . Whether a similar mechanism operates in mammalian enterocytes, and whether cGK II plays a role in this process, remains to be elucidated.
Consistent with the proposed function of cGK H as an effector of cGMP-provoked intestinal Cl -secretion, patch-clamp experiments have demonstrated that both the catalytic subunit of cAK and cGK II (48, and manuscript in preparation), but not cGK I (48, 49) can activate CFTR in excised patches of CFTR-transfected NIH-3T3 fibroblasts and rat intestinal IEC-6 cells. Certain other studies have alternatively implicated either the cAMP-dependent protein kinase (cAK) (9) (10) (11) or cGK I (50) as mediators of cGMP action on CFTR as well. One critical aspect of these studies, however, is that they were performed in cell lines (T84, Caco-2) which, at least in our experiments (Fig. 6) , contain no detectable amounts of cGK II or cGK I. Therefore conclusions made from these cells are predestined to neglect any contribution of the missing kinases, thus such cells may be unsuitable models for cGMP regulation of ion transport. In one report, however, a CFTR-like Cl -conductance in excised patches of T84 cells was proposed to be regulated by an endogenous membrane-associated cGK (50) , suggesting that some T84 cell clones may express cGK. Furthermore, unlike in intestine (3), STa can increase cGMP in T84 cells to submillimolar amounts (9) and could thereby activate cAK. In our studies in distal colon in which cGK II was absent as in the cell lines, STa however did not increase Isc by crossactivation of cAK, whereas the response to 8-Br-cAMP was intact (Table I) 
